Alcon Pre-Tax Profit Margin 2019-2022 | ALC
Current and historical pre-tax profit margin for Alcon (ALC) from 2019 to 2022. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue. Alcon pre-tax profit margin for the three months ending September 30, 2022 was .
| Alcon Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2022-09-30 |
$8.70B |
$0.64B |
7.30% |
| 2022-06-30 |
$8.66B |
$0.47B |
5.37% |
| 2022-03-31 |
$8.55B |
$0.51B |
5.95% |
| 2021-12-31 |
$8.29B |
$0.42B |
5.04% |
| 2021-09-30 |
$8.08B |
$0.38B |
4.71% |
| 2021-06-30 |
$7.82B |
$0.24B |
3.02% |
| 2021-03-31 |
$6.92B |
$-0.46B |
-6.60% |
| 2020-12-31 |
$6.83B |
$-0.64B |
-9.29% |
| 2020-09-30 |
$6.81B |
$-0.85B |
-12.43% |
| 2020-06-30 |
$6.84B |
$-0.74B |
-10.85% |
| 2020-03-31 |
$7.53B |
$-0.34B |
-4.47% |
| 2019-12-31 |
$7.51B |
$-0.33B |
-4.42% |
| 2019-06-30 |
$5.49B |
$-0.46B |
-8.36% |
| 2019-03-31 |
$5.41B |
$-0.34B |
-6.27% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$37.369B |
$8.291B |
|
Alcon Inc. researches, develops, manufactures, distributes, and sells a full suite of eye care products. Alcon operates within two segments, Surgical and Vision Care. The Surgical segment is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery, and includes implantables, consumables, and surgical equipment required for these procedures. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, and a comprehensive portfolio of ocular health products, including products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers.
|
